Condor Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-16,804
| Closed | -$176K | – | 165 |
|
|
2017
Q3 | $176K | Hold |
16,804
| – | – | 0.04% | 171 |
|
|
2017
Q2 | $185K | Hold |
16,804
| – | – | 0.04% | 173 |
|
|
2017
Q1 | $163K | Hold |
16,804
| – | – | 0.04% | 173 |
|
|
2016
Q4 | $175K | Hold |
16,804
| – | – | 0.04% | 177 |
|
|
2016
Q3 | $208K | Hold |
16,804
| – | – | 0.05% | 169 |
|
|
2016
Q2 | $180K | Hold |
16,804
| – | – | 0.04% | 169 |
|
|
2016
Q1 | $186K | Hold |
16,804
| – | – | 0.05% | 170 |
|
|
2015
Q4 | $205K | Hold |
16,804
| – | – | 0.05% | 172 |
|
|
2015
Q3 | $274K | Hold |
16,804
| – | – | 0.07% | 161 |
|
|
2015
Q2 | $356K | Hold |
16,804
| – | – | 0.09% | 157 |
|
|
2015
Q1 | $302K | Buy |
16,804
+6,183
| +58% | +$111K | 0.07% | 163 |
|
|
2014
Q4 | $182K | Hold |
10,621
| – | – | 0.05% | 162 |
|
|
2014
Q3 | $152K | Sell |
10,621
-1,963
| -16% | -$28.1K | 0.04% | 162 |
|
|
2014
Q2 | $189K | Sell |
12,584
-5,689
| -31% | -$85.4K | 0.05% | 156 |
|
|
2014
Q1 | $245K | Hold |
18,273
| – | – | 0.07% | 144 |
|
|
2013
Q4 | $147K | Sell |
18,273
-11,536
| -39% | -$92.8K | 0.05% | 152 |
|
|
2013
Q3 | $196K | Sell |
29,809
-18,377
| -38% | -$121K | 0.07% | 154 |
|
|
2013
Q2 | $296K | Buy |
+48,186
| New | +$296K | 0.11% | 138 |
|